other material
confidence low
sentiment neutral
materiality 0.50
Tarsus Pharmaceuticals launches proposed underwritten public offering of common stock
Tarsus Pharmaceuticals, Inc.
- Company commenced proposed underwritten public offering of common stock under existing shelf registration.
- Terminated unused ATM prospectus; no shares were ever sold under that program.
- Sales Agreement with Jefferies LLC remains in effect, pending new prospectus.
- No details on size, pricing, or timing of the offering were disclosed.